Quero Giuseppe, Fiorillo Claudio, De Sio Davide, Laterza Vito, Menghi Roberta, Cina Caterina, Schena Carlo Alberto, Rosa Fausto, Galiandro Federica, Alfieri Sergio
Pancreatic Surgery Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; CRMPG (Advanced Pancreatic Research Center), Largo A. Gemelli, 8, 00168, Roma, Italy; Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168, Roma, Italy.
Pancreatic Surgery Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; CRMPG (Advanced Pancreatic Research Center), Largo A. Gemelli, 8, 00168, Roma, Italy.
HPB (Oxford). 2021 Oct;23(10):1557-1564. doi: 10.1016/j.hpb.2021.03.011. Epub 2021 Apr 18.
Few evidences are available on the prognostic role of mesopancreas excision(MPe) for ampullary cancers(ACs). Aim of this study was to compare the long-term outcomes between pancreaticoduodenectomy(PD) with(PD-MPe group) and without(sPD group) MP.
Thirty-seven sPDs were matched and compared to 37 PD-MPes for perioperative outcomes, recurrence rate, disease-free(DFS) and overall survival(OS).
The PD-MPe technique related to a significantly higher number of harvested lymph nodes[16 (±6)] as compared to the sPD [10 (±5); p < 0.0001]. Tumor recurrence was more frequent in the sPD cohort[21 (56.8%) vs 12 (32.4%) in the PD-MPe population; p = 0.03]. Although not statistically different, PD-MPe was associated with a better DFS(40% vs 35.7% for sPD; p = 0.08) and OS(59.3% vs 39.1% for sPD; p = 0.07). At the multivariate analysis, a higher number of lymph nodes retrieved and a more extensive lymphovascular clearance reached with the MPe technique, together with lymph nodes metastases, were recognized as independent prognostic factors for a worse OS and DFS.
The PD-MPe technique is associated with a better oncological radicality thanks to the higher number of retrieved lymph nodes and to the more appropriate tumor clearance. This reflects in a lower incidence of tumor relapse and in improved outcomes in terms of OS and DFS.
关于中胰切除术(MPe)对壶腹癌(ACs)预后作用的证据很少。本研究的目的是比较胰十二指肠切除术(PD)联合(PD-MPe组)和不联合(sPD组)MP的长期疗效。
将37例sPD与37例PD-MPe在围手术期结果、复发率、无病生存期(DFS)和总生存期(OS)方面进行匹配和比较。
与sPD组[10(±5)个]相比,PD-MPe技术获取的淋巴结数量显著更多[16(±6)个];p<0.0001。sPD队列中的肿瘤复发更常见[21例(56.8%),而PD-MPe组为12例(32.4%);p=0.03]。虽然无统计学差异,但PD-MPe与更好的DFS(sPD组为40%,PD-MPe组为35.7%;p=0.08)和OS(sPD组为59.3%,PD-MPe组为39.1%;p=0.07)相关。在多变量分析中,MPe技术获取的淋巴结数量更多、淋巴血管清扫范围更广以及存在淋巴结转移被认为是OS和DFS较差的独立预后因素。
由于获取的淋巴结数量更多以及肿瘤清扫更合适,PD-MPe技术与更好的肿瘤根治性相关。这反映在肿瘤复发率较低以及OS和DFS方面的预后改善。